Clinical Trials Browser

Withdrawn × Urinary Bladder Neoplasms × durvalumab × Clear all

NCT04073160 2020-07-07

TRIO Bladder

Phase 1 Withdrawn

Urinary Bladder Neoplasms

NCT03150836 2017-10-19

Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer

Phase 2 Withdrawn

Urinary Bladder Neoplasms